Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$359,585
-$68,616 QoQ
Shares Held
993
-18.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#2,423
of 3,140 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wall Street Financial Group, Inc. holds $5,403,218 across 7 Drug Manufacturers - General names. AMGN ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,213 | $2,654,338 | |
| 2 | JNJ |
Johnson & Johnson
|
3,012 | $764,957 | |
| 3 | ABBV |
AbbVie Inc.
|
2,504 | $630,106 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,580 | $460,030 | |
| 5 | AMGN |
Amgen Inc
This page
|
993 | $359,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,552 | $322,419 | |
| 7 | PFE |
Pfizer Inc
|
8,795 | $211,783 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,585 | 993 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $428,201 | 1,217 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $279,378 | 990 | Shares | Sole | 2026-01-16 | |
| 2025-06-30 | $204,381 | 732 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||